Filing Details
- Accession Number:
- 0001645470-19-000033
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-29 11:06:09
- Reporting Period:
- 2019-05-22
- Accepted Time:
- 2019-05-29 11:06:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645470 | Brian Alan Collier | 6320 Canoga Avenue 15Th Floor Woodland Hills CA 91367 | Ceo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-22 | 5,000 | $0.01 | 22,925,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-22 | 2,000 | $0.01 | 22,927,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-22 | 25,000 | $0.01 | 22,952,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-22 | 10,000 | $0.01 | 22,962,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-22 | 2,000 | $0.01 | 22,964,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-22 | 5,000 | $0.01 | 22,969,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-22 | 20,000 | $0.01 | 22,989,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-22 | 5,000 | $0.01 | 22,994,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-22 | 5,000 | $0.01 | 22,999,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-23 | 5,000 | $0.01 | 23,004,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 5,000 | $0.01 | 23,009,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 5,000 | $0.01 | 23,014,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 10,000 | $0.01 | 23,024,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 40,000 | $0.01 | 23,064,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 10,000 | $0.01 | 23,074,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 10,000 | $0.01 | 23,084,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 20,000 | $0.01 | 23,104,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 20,000 | $0.01 | 23,124,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 20,000 | $0.01 | 23,144,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 20,000 | $0.01 | 23,164,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 20,000 | $0.01 | 23,184,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 20,000 | $0.01 | 23,204,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 50,000 | $0.01 | 23,254,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 20,000 | $0.01 | 23,274,397 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 200 | $0.01 | 23,274,597 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2019-05-24 | 20,000 | $0.01 | 23,294,597 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
